World Aquaculture Society Meetings


Your browser does not support the most current secure communications protocol. The World Aquaculture Society is committed to the security of your private information. In order to accept credit card data on this site we are recquired to be in compliance with Payment Card Industry (PCI) standards. Current PCI standards will not allow us to accept traffic from browsers that do not support TLS 1.2 after June 30, 2018. We are alerting you to the important need to update your browser. Changes to our web server made on or before June 30, 2018 will make unavailable with the browser you are currently using. [More..]

Add To Calendar 27/04/2016 14:50:0027/04/2016 15:10:00Africa/JohannesburgAsian-Pacific Aquaculture 2016FEED-BASED VACCINE: A PRACTICAL AND EFFECTIVE APPROACH AGAINST STREPTOCOCCOSIS IN CAGE-CULTURED RED TILAPIA IN MALAYSIA   Crystal 4The World Aquaculture Societyjohnc@was.orgfalseanrl65yqlzh3g1q0dme13067DD/MM/YYYY


Mohd-Syafiq, M.R.*, Siti-Zahrah, A., Ismail, M.S., Fahmi, S., Shahidan, H., Nur-Nazifah, M., Hanan, Y., Firdaus-Nawi., M. & Zamri-Saad, M.
National Fish Health Research Centre
Fisheries Research Institute (FRI) Batu Maung
11960 Penang, Malaysia

Streptococcosis in red tilapia is caused primarily by Streptococcos agalactiae and persists as a major disease problem in red tilapia both in Malaysia and other countries. Reported outbreaks have been reported as early as 2000 until now, causing high mortality resulting in high economic losses. Feed-based vaccine was thus developed to prevent Streptococcosis providing a more practical and easy measure for application. Therefore a field study was conducted in Kenyir Lake, Terengganu to evaluate the field efficacy of adjuvant inactivated vaccine (formalin-killed) incorporated in feed and administered orally following precise feeding regime. Three groups consisting of single booster, double booster and control group each was stocked with 1000 fishes/cage in duplicates at a selected endemic private farm during the critical period. Tilapia was vaccinated at 100 ± 20 g under field condition and sampling were done bimonthly for a period of 4 months. Samples were examined for prevalence rate of S.agalactiae including their antibody (IgM) titer. The mean prevalence rate for each group throughout study was recorded at 3.3%, 2.5% and 12.5%, respectively. At the end of study, survival of experimental group, double booster, single booster and control group was recorded at 75.1%, 65.3% and 47.2% respectively. High antibody titer recorded from double booster vaccination regime throughout the study showed that tilapia was protected against streptococcal infection. Thus oral vaccine could be a potential way of administration as it is easy and much more economical.

Copyright © 2001-2018 World Aquaculture Society All Rights Reserved.